Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual total long term liabilities is $0.00, unchanged on December 31, 2023.
- During the last 3 years, MACK annual total long term liabilities has risen by $0.00 (0.00%).
Performance
MACK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly total long term liabilities is $0.00, unchanged on March 1, 2024.
- Over the past year, MACK quarterly long term liabilities has stayed the same.
Performance
MACK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MACK Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | -100.0% | 0.0% |
MACK Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | at low |
| 5 y | 5-year | at high | at low | at high | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Merrimack Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(-100.0%) |
| Jun 2019 | - | $56.00 K(-99.6%) |
| Mar 2019 | - | $13.57 M(-9.1%) |
| Dec 2018 | $14.93 M(+1080.2%) | $14.93 M(+0.8%) |
| Sep 2018 | - | $14.81 M(>+9900.0%) |
| Jun 2018 | - | $56.00 K(-92.1%) |
| Mar 2018 | - | $707.00 K(-44.1%) |
| Dec 2017 | $1.26 M | $1.26 M(-97.6%) |
| Sep 2017 | - | $51.66 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $49.20 M(-79.2%) |
| Mar 2017 | - | $236.38 M(-3.9%) |
| Dec 2016 | $245.92 M(-21.9%) | $245.92 M(-4.3%) |
| Sep 2016 | - | $256.91 M(-1.5%) |
| Jun 2016 | - | $260.69 M(-16.7%) |
| Mar 2016 | - | $312.77 M(-0.7%) |
| Dec 2015 | $314.82 M(+110.6%) | $314.82 M(+111.9%) |
| Sep 2015 | - | $148.57 M(+6.3%) |
| Jun 2015 | - | $139.77 M(-8.4%) |
| Mar 2015 | - | $152.53 M(+2.0%) |
| Dec 2014 | $149.47 M(-15.9%) | $149.47 M(-10.5%) |
| Sep 2014 | - | $167.08 M(+43.9%) |
| Jun 2014 | - | $116.07 M(-33.3%) |
| Mar 2014 | - | $173.96 M(-2.2%) |
| Dec 2013 | $177.81 M(+52.1%) | $177.81 M(-1.0%) |
| Sep 2013 | - | $179.65 M(+66.8%) |
| Jun 2013 | - | $107.67 M(-3.1%) |
| Mar 2013 | - | $111.07 M(-5.0%) |
| Dec 2012 | $116.87 M(+44.6%) | $116.87 M(+42.5%) |
| Sep 2012 | - | $82.00 M(+3.9%) |
| Jun 2012 | - | $78.95 M(-77.5%) |
| Mar 2012 | - | $351.47 M(+334.8%) |
| Dec 2011 | $80.84 M(-68.9%) | $80.84 M(-76.2%) |
| Sep 2011 | - | $339.83 M(-0.7%) |
| Jun 2011 | - | $342.08 M(+27.9%) |
| Mar 2011 | - | $267.42 M(+2.8%) |
| Dec 2010 | $260.19 M(+37.8%) | $260.19 M |
| Dec 2009 | $188.82 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Merrimack Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Merrimack Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of MACK is $0.00
What is the all time high annual total long term liabilities for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual total long term liabilities is $314.82 M
What is Merrimack Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, MACK annual total long term liabilities has changed by $0.00 (0.00%)
What is Merrimack Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of MACK is $0.00
What is the all time high quarterly long term liabilities for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly total long term liabilities is $351.47 M
What is Merrimack Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, MACK quarterly total long term liabilities has changed by $0.00 (0.00%)